Viral Hepatitis

An infographic from HepVu on Hepatitis C.

Anti-Criminalization for Public Health Strategies highlights strategies that health departments and other public health agencies serving people who use drugs, engage in sex work, or who otherwise face increased health risks by being marginalized and criminalized are utilizing to push back on criminalization and its impacts. 

Abolition vs. Reform explores the differences between abolition-focused and reform-focused anti-criminalization work in health departments and other public health agencies serving people who use drugs, engage in sex work, or who otherwise face increased health risks due to marginalization.  

Criminalization as a Determinant of Public Health provides an overview of criminalization, impacts on public health, and the importance of public health practitioners to learn more about criminalization. 

This guide has been written collaboratively by people with lived experience of substance use, nursing students, harm reductionists, and medical professionals to address medical issues that may affect people who use drugs.

This infographic discusses how in 2018, injection drug use (IDU) was highest among men (21%),

This video discusses an overview of the new GHSS, the five strategic directions, and the 2025 and 2030 targets. 

The progress countries have made to these goals and what needs to be done to achieve them.   

How community-based organizations and activists can use the GHSS and its targets for advocacy and to hold countries and health systems accountable to their commitments.  

Good practice examples of using the previous GHSS for advocacy and how countries have used GHSS in the planning and implementation of their national programmes.  

This packet of recommendations discusses how in October 2022, INHSU Prisons and the Coalition for Global Hepatitis Elimination (CGHE), Task Force for Global Health convened a workshop on the strategies for expanding access to hepatitis C virus (HCV) prevention, testing, and treatment in prison settings. During the workshop, barriers and recommendations to accelerating HCV elimination in prison settings were examined in four areas: 1) Policy, 2) Implementation, 3) Financing, and 4) Awareness.

This video makes healthcare providers aware of the HIV/HCV co-infection patient engagement tools developed by the AETC Program, which helps providers who care for people co-infected with HIV & HCV stay engaged in their HCV care to achieve a sustained virologic response.